Lise currently manages various iPSC reprogramming, gene editing, cell banking, scale-up and differentiation projects. For over 8 years, her team has been focused on enabling these processes for manufacturing in GMP environments to produce clinically relevant doses of cell therapy products. This has been done through a thoughtful planning to ensure that the process, analytical controls, technology licenses, specialized staff recruitment, training and GMP documentation were in place. The initial successes from these efforts have been used as models for other internal technology platforms including immunotherapy. Lise earned her PhD at McMaster University focusing on drug discovery in neurodegenerative diseases. Following this, she completed a post-doctoral research fellowship at the Centre for Applied Neurogenetics at the University of British Columbia where she focused on genetic causes of Parkinson’s Disease.